Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964886 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Antidepressants in Chronic Back Pain
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 142
- Enrollment target
NCT00964886: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00964886 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 142 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964886, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 142 participants
- Enrollment target
Study Summary
This 12 week placebo controlled clinical trial tests the individual and combined effects of an antidepressant medication and cognitive behavioral therapy for chronic back pain.
Interventions
- BEHAVIORAL cognitive behavioral therapy
- DRUG desipramine hydrochloride
- DRUG benztropine mesylate 0.125 mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964886
The ClinicalTrials.gov registry entry for NCT00964886 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which cognitive behavioral therapy is the first listed.
NCT00964886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964886 about?
NCT00964886 is a clinical study titled "Efficacy of Antidepressants in Chronic Back Pain". This 12 week placebo controlled clinical trial tests the individual and combined effects of an antidepressant medication and cognitive behavioral therapy for chronic back pain.
What is the current status of trial NCT00964886?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2010-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00964886?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), desipramine hydrochloride (DRUG), benztropine mesylate 0.125 mg daily (DRUG).
Who is sponsoring clinical trial NCT00964886?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.